Literature DB >> 6215365

High- and low-leukemogenic variants of the radiation leukemia virus (RadLV) differ in ability to induce tumor-specific immune suppression.

E Yefenof, D Zilcha.   

Abstract

Adult C57BL/6 mice inoculated intrathymically (i.t.) with the highly leukemogenic variant of the radiation leukemia virus (A-RadLV) develop suppressor cells capable of specifically abrogating a potential anti-tumor cytotoxic response in vitro. Suppressor cells were generated directly by the virus, independently of an initiation of a leukemogenic process. Inoculation of C57BL/6 animals with the low leukemogenic D-RadLV variant did not result in suppressor cell generation. It is proposed that induction of tumor-specific immune suppression by A-RadLV is essential for tumor progression, and the leukemogenic activity of D-RadLV is attributed to its inability to recruit suppressor cells.

Entities:  

Mesh:

Year:  1982        PMID: 6215365     DOI: 10.1002/ijc.2910300316

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  2 in total

1.  Potentiation of T cell immunity against radiation-leukemia-virus-induced lymphoma by polysaccharide K.

Authors:  E Yefenof; E Einat; E Klein
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Suppressor and reactive lymphocytes in radiation leukemia virus (RadLV)-induced leukemogenesis.

Authors:  E Yefenof; Y Ben-David
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.